Oram Jeffrey 4
4 · Alzamend Neuro, Inc. · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Oram Jeffrey
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-15+50,000→ 100,000 total - Exercise/Conversion
Restricted Stock Grant
2022-03-15−50,000→ 0 totalExp: 2022-03-15→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents the vesting of restricted stock.
- [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F3]2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022.